Phase 2 open-label study of amonafide L-malate in combination with cytarabine in subjects with secondary acute myeloid leukemia (AML)

Trial Profile

Phase 2 open-label study of amonafide L-malate in combination with cytarabine in subjects with secondary acute myeloid leukemia (AML)

Completed
Phase of Trial: Phase II

Latest Information Update: 05 Jun 2010

At a glance

  • Drugs Amonafide; Cytarabine
  • Indications Acute myeloid leukaemia
  • Focus Therapeutic Use
  • Sponsors Antisoma
  • Most Recent Events

    • 05 Jun 2010 Results presented at the ASCO 2010, according to a Antisoma media release.
    • 07 Dec 2009 Final results presented at the 51st Annual Meeting and Exposition of the American Society of Hematology (ASH 2009), according to a Antisoma media release.
    • 09 Dec 2008 Updated results were presented at the 50th Annual Meeting of the American Society of Hematology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top